Format

Send to

Choose Destination
Nat Rev Drug Discov. 2011 Dec 1;10(12):945-63. doi: 10.1038/nrd3599.

Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Author information

1
Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, College of Medicine, 900 S. Ashland Avenue, Chicago, Illinois 60607, USA.

Abstract

Members of the CCN family of matricellular proteins are crucial for embryonic development and have important roles in inflammation, wound healing and injury repair in adulthood. Deregulation of CCN protein expression or activities contributes to the pathobiology of various diseases - many of which may arise when inflammation or tissue injury becomes chronic - including fibrosis, atherosclerosis, arthritis and cancer, as well as diabetic nephropathy and retinopathy. Emerging studies indicate that targeting CCN protein expression or signalling pathways holds promise in the development of diagnostics and therapeutics for such diseases. This Review summarizes the biology of CCN proteins, their roles in various pathologies and their potential as therapeutic targets.

PMID:
22129992
PMCID:
PMC3663145
DOI:
10.1038/nrd3599
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center